<div id="readability-page-1"><div> <p>By Katherine Hamilton</p> <pre></pre> <p>   Nike recorded a lower profit and said it expects revenue to a decline in its current quarter. The stock fell 11% to $58.62 in after-hours trading Thursday. </p> <p>   Cassava Sciences said the FDA had placed a hold on its trial for a drug to treat epilepsy. Shares slid 13% to $2.49 after the bell. </p> <p>   KB Home delivered fewer homes and recorded a lower profit in its most recent quarter. The stock declined 3.6% to $60.50. </p> <pre></pre> <p>   Write to Katherine Hamilton at katherine.hamilton@wsj.com </p> <pre></pre> <p>   (END) Dow Jones Newswires</p> <p>   December 18, 2025 18:54 ET (23:54 GMT)</p><p>Copyright (c) 2025 Dow Jones &amp; Company, Inc.</p></div></div>

SAVA

<p>Nike's stock fell 11% to $58.62 after reporting lower profit and expected revenue decline. Cassava Sciences' shares slid 13% to $2.49 after FDA halted its epilepsy drug trial. KB Home's stock declined 3.6% to $60.50 due to fewer homes delivered and lower profit.</p>

Stocks to Watch: Nike, Cassava Sciences, KB Home